Literature DB >> 3319280

Study of the immune complex precipitation-inhibiting capacity of sera of patients with chronic lymphocytic leukaemia.

L Varga1, Z Miszlay, E Czink, K Pálóczi, G Szegedi, G Füst, S R Hollán.   

Abstract

Two procedures measuring the capacity of different sera to prevent the precipitation of nascent immune complexes were compared: a kinetic method with a constant immune complex/serum ratio and a new procedure--the increasing immune complex load method--using different immune complex/serum ratios. Immune complex precipitation inhibition is known to depend on complement. The sera of 25 patients with chronic lymphocytic leukaemia (CLL) and the sera of nine healthy blood donors were compared with the two procedures. The kinetic method discriminated poorly between the patients' sera and the control sera, whereas the increasing immune complex load method showed a highly significant difference between the two groups. Sera with low C4 level had the lowest immune complex precipitation-inhibiting activity. Interestingly, however, in the increasing immune complex load method not only hypocomplementaemic but also normocomplementaemic sera from CLL patients were found to be markedly defective. This finding suggests that the CLL patients' sera contain a factor which modulates complement-dependent inhibition of immune complexes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319280

Source DB:  PubMed          Journal:  Diagn Clin Immunol        ISSN: 0895-0458


  2 in total

1.  BSA-anti-BSA immune complexes formed in the presence of human complement do not bind to autologous red blood cells.

Authors:  L Varga; E Thiry; G Füst
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

2.  Low activity of the classical complement pathway predicts short survival of patients with chronic lymphocytic leukaemia.

Authors:  L Varga; E Czink; Z Miszlai; K Pálóczi; A Bányai; G Szegedi; G Füst
Journal:  Clin Exp Immunol       Date:  1995-01       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.